Skip to main content
. 2020 May 26;12(10):9461–9474. doi: 10.18632/aging.103219

Figure 1.

Figure 1

Evaluation of compounds on cell viability (A) cell viability after MPP+ treatment; (B) cell viability after MB-3 treatment; (C) cell viability after SRC-3 treatment; (D) cell viability after SB203580 treatment; (E) cell viability after isoproterenol treatment; (F) cell viability after Compound C treatment; (G) cell viability after AICAR treatment. * P < 0.05, ** P < 0.01.